AzTrials
AzTrials

Shoulder DislocationEPAULUXNCT05635240

Chronic Anterior Shoulder Instability in the Military

An observational study of Shoulder Dislocation, run by Direction Centrale du Service de Santé des Armées at 2 sites in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Anterior shoulder instability is a chronic condition that occurs after an anteromedial dislocation. Its prevalence is high in athletes but has been little studied in the armed forces. In general, patients with a first episode of dislocation have a 1 in 2 chance of experiencing at least one recurrence. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Shoulder Dislocation
What is being tested?
Interview / questionnaires
How many people
120 participants
Where
2 sitesFrance
Study dates
Sep 2023to Sep 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will be composed of French military member with a first episode of true anterior glenohumeral shoulder dislocation.

Who may be able to join

  • Military member with a first episode of true anterior glenohumeral shoulder dislocation,
  • Male or female,
  • Major,
  • Having a sufficient level of reading/writing of the French language,
  • Did not object to participating in the study.

Who cannot join

  • Patient with a history of homolateral shoulder dislocation or surgery on the affected shoulder,
  • Collagen disease confirmed by genetic testing,
  • Inflammatory arthropathy,
  • History of rotator cuff injury,
  • Insufficient French reading/writing skills,
  • Under legal protection,
  • Objection to participating in the study.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

France2 sites
  • Hôpital d'Instruction des Armées Percy

    Clamart, 92140

    Alexandre SABATE FERRIS, MD, alexandre.sabate-ferris@intradef.gouv.fr

  • Direction Médicale des Forces

    Tours, 37076

    Romain MONTAGNON, MD, 563245110 ext. +33, romain1.montagnon@intradef.gouv.fr

Other trials in France

About this study

Anterior shoulder instability is a chronic condition that occurs after an anteromedial dislocation. Its prevalence is high in athletes but has been little studied in the armed forces. In general, patients with a first episode of dislocation have a 1 in 2 chance of experiencing at least one recurrence. The more recurrences there are, the more damage there is to the joint and the greater the disability for the patient. The decree determining the medical aptitude of military personnel emphasizes the need to have recourse to a specialized consultation to determine the classification of the soldier after a first episode of dislocation. In the absence of data collected specifically in the military population, classification is based on the surgeon's experience and extrapolation of results obtained in the general population.

Being tested
Interview / questionnaires
Medical subject headings
Shoulder Dislocation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interview / questionnairesOther

    At each of the 4 visits, the participant will have to answer several questions regarding trauma-related data, employment and sport practice.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of patients with a new episode of true anterior glenohumeral shoulder dislocation or subluxation 1 year after the initial dislocation.

    A true anterior glenohumeral shoulder dislocation is defined as a dislocation requiring reduction.

    Dislocation and subluxation will have to be objectified by medical examination

    Measured: Through study completion (72 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2022
  2. Study startSep 2023 (estimated)
  3. Primary completionSep 2029 (estimated)
  4. Study completionSep 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05635240
Sponsor's protocol ID
2019PPRC13
Other IDs
2022-A02091-42
Acronym
EPAULUX
Status last verified
Apr 2023
First submitted
23 Nov 2022
Last updated
28 Apr 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Shoulder Dislocation, run by Direction Centrale du Service de Santé des Armées at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alexandre SABATE FERRIS, MD (141466000 ext. +33, alexandre.sabate-ferris@intradef.gouv.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of patients with a new episode of true anterior glenohumeral shoulder dislocation or subluxation 1 year after the initial dislocation. (time frame: Through study completion (72 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in